arrow_back Back to App

Increased Brain Aneurysm Research: Ellie's Law

Ellie's Law boosts funding for research into unruptured intracranial aneurysms at the National Institute of Neurological Disorders and Stroke. This aims to better understand a condition affecting millions of Americans and improve treatment methods, potentially saving lives and reducing suffering for many families. Increased research could lead to earlier detection and more effective treatments, mitigating tragic outcomes.
Key points
Increases funding for brain aneurysm research by $10 million annually for five years (2022-2026).
Research will include a broader patient population, diversified by age, sex, and race, for a better understanding of the condition.
Aims to improve diagnosis and treatment of unruptured aneurysms, potentially preventing ruptures and their fatal or debilitating consequences.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_1553
Sponsor: Rep. Clarke, Yvette D. [D-NY-9]
Process start date: 2021-03-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Ellie’s Law

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_1553.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-03.

What are the main provisions?

Key points include:

  • Increases funding for brain aneurysm research by $10 million annually for five years (2022-2026).
  • Research will include a broader patient population, diversified by age, sex, and race, for a better understanding of the condition.
  • Aims to improve diagnosis and treatment of unruptured aneurysms, potentially preventing ruptures and their fatal or debilitating consequences.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Clarke, Yvette D. [D-NY-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health